Revenue
$3.77B
Fiscal year ended 2025-12-31Operating income
-$22.10M
Fiscal year ended 2025-12-31Free cash flow
$23.60M
Fiscal year ended 2025-12-31HYSTER-YALE, INC. (HY) reported revenue of $3.77B and net income of -$60.10M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from HYSTER-YALE, INC.’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.77B | $4.31B | $4.12B | $3.55B | $3.08B | $2.81B | $3.29B | $3.18B | $2.89B | $2.57B |
| Cost of revenue | $3.14B | $3.41B | $3.33B | $3.11B | $2.71B | $2.35B | $2.75B | $2.68B | $2.38B | $2.14B |
| Gross profit | $632.80M | $895.50M | $785.60M | $433.90M | $363.40M | $465.40M | $541.80M | $497.00M | $502.60M | $427.50M |
| Operating income | -$22.10M | $244.80M | $208.70M | -$39.10M | -$152.30M | $49.90M | $53.90M | $38.80M | $74.10M | $32.90M |
| Net income | -$60.10M | $142.30M | $125.90M | -$74.10M | -$173.00M | $37.10M | $35.80M | $34.70M | $48.60M | $42.80M |
| Research & development | $137.20M | $135.90M | $119.70M | $100.70M | $108.30M | $100.50M | $115.30M | $110.90M | $104.50M | $107.00M |
| Weighted-average diluted shares | shares 17.67M | shares 17.71M | shares 17.38M | shares 16.90M | shares 16.82M | shares 16.80M | shares 16.73M | shares 16.60M | shares 16.51M | shares 16.43M |
| Pretax income | -$42.90M | $219.00M | $181.00M | -$62.40M | -$154.90M | $42.20M | $47.90M | $36.60M | $93.80M | $38.30M |
| Income tax expense | $15.10M | $74.80M | $52.90M | $9.20M | $28.30M | $3.70M | $11.30M | $2.30M | $44.90M | -$4.00M |
| Diluted EPS | $-3.40 | $8.04 | $7.24 | $-4.38 | $-10.29 | $2.21 | $2.14 | $2.09 | $2.94 | $2.61 |
| Selling, general & administrative | $616.50M | $628.10M | $576.90M | $473.00M | $450.10M | $415.50M | $487.90M | $458.20M | $428.50M | $394.60M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | $65.50M | $151.40M | $64.60M | $83.70M | $220.10M | $43.20M |
| Total assets | $2.02B | $2.03B | $2.08B | $2.03B | $1.97B | $1.86B | $1.85B | $1.74B | $1.65B | $1.29B |
| Current assets | $1.35B | $1.43B | $1.49B | $1.46B | $1.35B | $1.13B | $1.16B | $1.13B | $1.13B | $810.00M |
| Total liabilities | $1.53B | $1.54B | $1.67B | $1.80B | $1.59B | $1.21B | $1.27B | $1.18B | $1.08B | $816.70M |
| Current liabilities | $1.00B | $1.06B | $1.22B | $1.34B | $1.10B | $755.90M | $817.00M | $776.20M | $692.40M | $576.50M |
| Total equity incl. NCI | $476.30M | $479.20M | $392.00M | $210.90M | $382.90M | $651.10M | $577.00M | $559.50M | $572.40M | $470.40M |
| Temporary (mezzanine) equity | $16.10M | $14.90M | $14.80M | $14.20M | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $634.30M | $754.30M | $815.70M | $799.50M | $781.00M | $509.40M | $559.90M | $533.60M | $411.90M | $352.20M |
| Accounts receivable | $489.60M | $488.40M | $497.50M | $523.60M | $457.40M | $412.10M | $468.30M | $465.50M | $453.00M | $375.30M |
| Goodwill | $55.70M | $54.60M | $53.30M | $51.30M | $56.50M | $114.70M | $106.70M | $108.30M | $59.10M | $50.70M |
| Long-term debt | $251.90M | $241.90M | $241.30M | $267.00M | $261.70M | $206.10M | $204.70M | $210.10M | $216.20M | $82.20M |
| Accounts payable | $396.10M | $447.80M | $523.50M | $585.80M | $517.00M | $412.00M | $401.50M | $415.50M | $385.80M | $242.40M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $86.10M | $170.70M | $150.70M | $40.60M | -$253.50M | $166.90M | $76.70M | $67.60M | $164.70M | -$48.90M |
| Capital expenditures | $62.50M | $47.80M | $35.40M | $28.80M | $44.30M | $51.70M | $49.70M | $38.80M | $41.00M | $42.70M |
| Investing cash flow | -$62.70M | -$47.60M | -$34.50M | -$35.40M | -$24.50M | -$43.70M | -$42.00M | -$110.90M | -$47.30M | -$145.10M |
| Financing cash flow | -$800.00K | -$100.10M | -$100.50M | -$10.90M | $193.60M | -$40.60M | -$51.60M | -$87.60M | $53.10M | $77.90M |
| Net change in cash | $26.60M | $17.80M | $19.80M | -$6.50M | -$85.90M | $86.80M | -$19.10M | -$136.40M | $176.90M | -$111.90M |
| Stock-based compensation | $7.50M | $23.60M | $29.30M | $6.40M | $4.00M | $1.30M | $8.20M | $5.70M | $8.80M | $4.90M |
| Common dividends paid | $25.40M | $24.00M | $22.30M | $21.80M | $21.60M | $21.30M | $21.00M | $20.40M | $19.80M | $19.20M |
| Common share repurchases | -$4.50M | -$14.00M | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 |
| Depreciation & amortization | $45.80M | $47.60M | $45.10M | $43.40M | $46.20M | $42.90M | $43.30M | $44.00M | $42.80M | $39.10M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $23.60M | $122.90M | $115.30M | $11.80M | -$297.80M | $115.20M | $27.00M | $28.80M | $123.70M | -$91.60M |
| Gross margin | 16.8% | 20.8% | 19.1% | 12.2% | 11.8% | 16.5% | 16.5% | 15.6% | 17.4% | 16.6% |
| Operating margin | -0.6% | 5.7% | 5.1% | -1.1% | -5.0% | 1.8% | 1.6% | 1.2% | 2.6% | 1.3% |
| FCF margin | 0.6% | 2.9% | 2.8% | 0.3% | -9.7% | 4.1% | 0.8% | 0.9% | 4.3% | -3.6% |
| SBC / revenue | 0.2% | 0.5% | 0.7% | 0.2% | 0.1% | 0.0% | 0.2% | 0.2% | 0.3% | 0.2% |
| Current ratio | 1.34x | 1.35x | 1.22x | 1.09x | 1.22x | 1.49x | 1.41x | 1.46x | 1.63x | 1.41x |
| Revenue YoY growth | -12.5% | 4.6% | 16.1% | 15.4% | 9.4% | -14.6% | 3.5% | 10.2% | 12.3% | Unavailable |
| Net margin | -1.6% | 3.3% | 3.1% | -2.1% | -5.6% | 1.3% | 1.1% | 1.1% | 1.7% | 1.7% |
| R&D / revenue | 3.6% | 3.2% | 2.9% | 2.8% | 3.5% | 3.6% | 3.5% | 3.5% | 3.6% | 4.2% |
| CapEx / revenue | 1.7% | 1.1% | 0.9% | 0.8% | 1.4% | 1.8% | 1.5% | 1.2% | 1.4% | 1.7% |
| Long-term debt / equity | 0.53x | 0.50x | 0.62x | 1.27x | 0.68x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | 34.2% | 29.2% | Unavailable | Unavailable | 8.8% | 23.6% | 6.3% | 47.9% | -10.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HY in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-03-03View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-06View SEC filing
Companies in the same industry
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.